NCT01472965View on ClinicalTrials.gov

Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

December 29, 2011

Primary Completion Date

November 11, 2016

Study Completion Date

November 11, 2016

Conditions
Central Line-Associated Bloodstream Infection
Interventions
DRUG

ethanol

70% ethanol catheter lock therapy

DRUG

heparin-saline placebo

heparin-saline placebo catheter lock therapy

Trial Locations (2)

3052

Royal Children's Hospital Melbourne, Parkville

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT01472965 - Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection | Biotech Hunter | Biotech Hunter